245 related articles for article (PubMed ID: 26458884)
1. Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II+ detection rates.
Rozemeijer K; Penning C; Siebers AG; Naber SK; Matthijsse SM; van Ballegooijen M; van Kemenade FJ; de Kok IM
Cancer Causes Control; 2016 Jan; 27(1):15-25. PubMed ID: 26458884
[TBL] [Abstract][Full Text] [Related]
2. Cervical cancer incidence after normal cytological sample in routine screening using SurePath, ThinPrep, and conventional cytology: population based study.
Rozemeijer K; Naber SK; Penning C; Overbeek LI; Looman CW; de Kok IM; Matthijsse SM; Rebolj M; van Kemenade FJ; van Ballegooijen M
BMJ; 2017 Feb; 356():j504. PubMed ID: 28196844
[No Abstract] [Full Text] [Related]
3. Cervical histology after routine ThinPrep or SurePath liquid-based cytology and computer-assisted reading in Denmark.
Rebolj M; Rask J; van Ballegooijen M; Kirschner B; Rozemeijer K; Bonde J; Rygaard C; Lynge E
Br J Cancer; 2015 Nov; 113(9):1259-74. PubMed ID: 26448176
[TBL] [Abstract][Full Text] [Related]
4. Comparison of SurePath® and ThinPrep® liquid-based cervical cytology using positive predictive value, atypical predictive value and total predictive value as performance indicators.
Wright PK; Marshall J; Desai M
Cytopathology; 2010 Dec; 21(6):374-8. PubMed ID: 20545727
[TBL] [Abstract][Full Text] [Related]
5. Comparison of ThinPrep and SurePath liquid-based cytology and subsequent human papillomavirus DNA testing in China.
Zhao FH; Hu SY; Bian JJ; Liu B; Peck RB; Bao YP; Pan QJ; Frappart L; Sellors J; Qiao YL
Cancer Cytopathol; 2011 Dec; 119(6):387-94. PubMed ID: 21774094
[TBL] [Abstract][Full Text] [Related]
6. Cytology versus HPV testing for cervical cancer screening in the general population.
Koliopoulos G; Nyaga VN; Santesso N; Bryant A; Martin-Hirsch PP; Mustafa RA; Schünemann H; Paraskevaidis E; Arbyn M
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008587. PubMed ID: 28796882
[TBL] [Abstract][Full Text] [Related]
7. Performance of the CellSolutions Glucyte liquid-based cytology in comparison with the ThinPrep and SurePath methods.
Alaghehbandan R
Acta Cytol; 2013; 57(2):189-97. PubMed ID: 23407055
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity of high-risk HPV Hybrid Capture II (hrHPV HC2) test using SurePath(TM) specimens in the prediction of cervical high-grade squamous lesions.
Zhou F; Pulinthanathu R; Elgert P; Cangiarella J; Simsir A
Diagn Cytopathol; 2015 May; 43(5):381-7. PubMed ID: 25546355
[TBL] [Abstract][Full Text] [Related]
9. Liquid-based cytology: evaluation of effectiveness, cost-effectiveness, and application to present practice.
Cox JT
J Natl Compr Canc Netw; 2004 Nov; 2(6):597-611. PubMed ID: 19780303
[TBL] [Abstract][Full Text] [Related]
10. A randomised comparison of SurePath liquid-based cytology and conventional smear cytology in a colposcopy clinic setting.
Sykes PH; Harker DY; Miller A; Whitehead M; Neal H; Wells JE; Peddie D
BJOG; 2008 Oct; 115(11):1375-81. PubMed ID: 18823488
[TBL] [Abstract][Full Text] [Related]
11. Comparison between Conventional Cytology and Liquid-Based Cytology in the Tertiary Brazilian Navy Hospital in Rio de Janeiro.
de Oliveira ACA; Domingues MF; Neufeld PM; Fleury M; Nogueira Neto JF
Acta Cytol; 2020; 64(6):539-546. PubMed ID: 32516778
[TBL] [Abstract][Full Text] [Related]
12. A comparison of liquid-based and conventional cytology using data for cervical cancer screening from the Japan Cancer Society.
Ito K; Kimura R; Konishi H; Ozawa N; Yaegashi N; Ohashi Y; Suzuki M; Kakizoe T
Jpn J Clin Oncol; 2020 Feb; 50(2):138-144. PubMed ID: 31735963
[TBL] [Abstract][Full Text] [Related]
13. Comparison of ThinPrep Integrated Imager-Assisted Screening versus Manual Screening of ThinPrep Liquid-Based Cytology Specimens.
Tanaka K; Aoki D; Tozawa-Ono A; Suzuki N; Takamatsu K; Nakamura M; Tsunoda H; Seino S; Kobayashi N; Shirayama T; Takahashi F
Acta Cytol; 2020; 64(5):486-491. PubMed ID: 32535593
[TBL] [Abstract][Full Text] [Related]
14. Can Genomic Amplification of Human Telomerase Gene and C-MYC in Liquid-Based Cytological Specimens Be Used as a Method for Opportunistic Cervical Cancer Screening?
Gao K; Eurasian M; Zhang J; Wei Y; Zheng Q; Ye H; Li L
Gynecol Obstet Invest; 2015; 80(3):153-63. PubMed ID: 25832290
[TBL] [Abstract][Full Text] [Related]
15. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
Leinonen M; Nieminen P; Kotaniemi-Talonen L; Malila N; Tarkkanen J; Laurila P; Anttila A
J Natl Cancer Inst; 2009 Dec; 101(23):1612-23. PubMed ID: 19903804
[TBL] [Abstract][Full Text] [Related]
16. The reporting rates of high-grade squamous intraepithelial lesions and their human papillomavirus testing and histologic follow-up results: A comparison between ThinPrep and SurePath preparations.
Sinclair WD; Gibbons-Fideler IS; Shen R; Li Z
Diagn Cytopathol; 2021 Aug; 49(8):959-963. PubMed ID: 33991062
[TBL] [Abstract][Full Text] [Related]
17. Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trial.
Siebers AG; Klinkhamer PJ; Grefte JM; Massuger LF; Vedder JE; Beijers-Broos A; Bulten J; Arbyn M
JAMA; 2009 Oct; 302(16):1757-64. PubMed ID: 19861667
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Efficacy in Abnormal Cervical Cell Detection between Liquid-based Cytology and Conventional Cytology.
Tanabodee J; Thepsuwan K; Karalak A; Laoaree O; Krachang A; Manmatt K; Anontwatanawong N
Asian Pac J Cancer Prev; 2015; 16(16):7381-4. PubMed ID: 26514540
[TBL] [Abstract][Full Text] [Related]
19. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
Juric D; Mahovlić V; Rajhvajn S; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Projić IS; Babić D; Susa M; Corusić A; Oresković S
Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728
[TBL] [Abstract][Full Text] [Related]
20. [Health technology assessment report. Use of liquid-based cytology for cervical cancer precursors screening].
Ronco G; Confortini M; Maccallini V; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Giorgi Rossi P
Epidemiol Prev; 2012; 36(5 Suppl 2):e1-e33. PubMed ID: 23139163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
